ICU Medical stock gains as margin and price data hold

Published on 09/05/2026 at 22:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ICU Medical stock stays in view after fresh market data and the latest reported quarter. Investors are watching revenue, margin and the current valuation setup.

ICUI, US44930G1076, Illustration mit AI erstellt.

ICU Medical Inc. (US44930G1076) stock gained 0.78 percent to USD 167.58, with a market value of USD 4.191 billion, according to Yahoo Finance on September 5, 2026. The same data set shows ICU Medical at a current price-to-sales ratio of 1.63 and a current price-to-earnings ratio of 17.52.

Latest quarter still matters

Yahoo Finance still points to the latest reported quarter for ICU Medical in 2026, while Morningstar shows the company against peers such as Becton Dickinson and ResMed on valuation and return metrics. For investors, the combination of a USD 4.191 billion market cap and a 17.52 normalized P/E keeps the stock in a valuation-sensitive zone.

Morningstar also lists ICU Medical with a quick ratio of 0.99, a current ratio of 2.34 and a return on invested capital of 4.97 percent. That mix suggests the balance sheet is solid, but capital efficiency remains the key comparison point.

Peers frame the move

In the same peer table, Morningstar shows ICU Medical with a normalized P/E of 17.52 versus 10.70 for Becton Dickinson and 9.61 for Baxter. The gap is concrete: ICU Medical trades at 6.82 points above BDX on that measure and 7.91 points above BAX.

A second valuation split stands out as well. Morningstar lists ICU Medical at a price-to-sales ratio of 1.63, compared with 2.00 for Becton Dickinson and 0.90 for Baxter.

Go deeper

ICU Medical stock and the latest quarter

The latest data point is the stock price, while the peer table gives the clearest read on how ICU Medical is valued against larger medtech names.

Infusion systems drive the story

ICU Medical remains tied to infusion therapy, vascular access and consumables, which is why recurring revenue quality matters as much as headline growth. The current peer data suggests the market is still paying for that profile, even as efficiency metrics stay below some rivals.

Trading level to watch

As of September 5, 2026, ICU Medical stock trades at USD 167.58, with a market capitalization of USD 4.191 billion. The 0.78 percent move on the day leaves the shares close enough to the current valuation backdrop to keep the debate centered on earnings quality rather than price alone.